These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 7951231

  • 21. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
    Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner VF.
    J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
    [Abstract] [Full Text] [Related]

  • 22. Molecular biology of vestibular schwannomas.
    Chang LS, Welling DB.
    Methods Mol Biol; 2009 May; 493():163-77. PubMed ID: 18839347
    [Abstract] [Full Text] [Related]

  • 23. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
    Kluwe L, Mautner VF.
    Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
    [Abstract] [Full Text] [Related]

  • 24. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
    Bian LG, Tirakotai W, Sun QF, Zhao WG, Shen JK, Luo QZ.
    J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
    [Abstract] [Full Text] [Related]

  • 25. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A, Neary WJ, Wallace A, Wu CL, Purcell S, Reid H, Ramsden RT, Read A, Black G, Evans DG.
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [Abstract] [Full Text] [Related]

  • 26. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
    Sainz J, Figueroa K, Baser ME, Pulst SM.
    Hum Genet; 1996 Jan; 97(1):121-3. PubMed ID: 8557252
    [Abstract] [Full Text] [Related]

  • 27. Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
    Wallace AJ, Watson CJ, Oward E, Evans DG, Elles RG.
    Genet Test; 2004 Jan; 8(4):368-80. PubMed ID: 15684865
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG.
    Oncogene; 2010 Nov 25; 29(47):6216-21. PubMed ID: 20729918
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst SM.
    J Neuropathol Exp Neurol; 1997 Apr 25; 56(4):382-90. PubMed ID: 9100669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
    MacCollin M.
    Brain Dev; 1995 Apr 25; 17(4):231-8. PubMed ID: 7503383
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
    Faudoa R, Xue Z, Lee F, Baser ME, Hung G.
    Hum Mutat; 2000 Apr 25; 15(5):474-8. PubMed ID: 10790209
    [Abstract] [Full Text] [Related]

  • 36. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R, Bartelt-Kirbach B, Evans DG, Kaufmann D, Hanemann CO.
    J Mol Diagn; 2005 Feb 25; 7(1):97-104. PubMed ID: 15681480
    [Abstract] [Full Text] [Related]

  • 37. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
    Kehrer-Sawatzki H, Udart M, Krone W, Baden R, Fahsold R, Thomas G, Schmucker B, Assum G.
    Hum Genet; 1997 Jul 25; 100(1):67-74. PubMed ID: 9225971
    [Abstract] [Full Text] [Related]

  • 38. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN.
    Am J Pathol; 1997 Dec 25; 151(6):1649-54. PubMed ID: 9403715
    [Abstract] [Full Text] [Related]

  • 39. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP.
    Hum Genet; 1999 May 25; 104(5):418-24. PubMed ID: 10394935
    [Abstract] [Full Text] [Related]

  • 40. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N, Seizinger BR.
    Cancer Surv; 1995 May 25; 25():207-18. PubMed ID: 8718520
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.